Delivering Value To Those We Serve

Assertio Therapeutics to Present at the 16th Annual Morgan Stanley Global Healthcare Conference

September 5, 2018 at 8:00 AM EDT

LAKE FOREST, Ill., Sept. 05, 2018 (GLOBE NEWSWIRE) -- Assertio Therapeutics, Inc. (NASDAQ: ASRT), a leading specialty pharmaceutical company committed to advancing patient care, today announced that members of senior management will participate at the 16th Annual Morgan Stanley Global Healthcare Conference in a session scheduled for 12:55 p.m. ET, Thursday, September 13, 2018 in New York, NY.

This presentation will be webcast and can be accessed via the Investor Relations page of the Assertio website at www.assertiotx.com. A recording of the webcast will be archived.

About Assertio Therapeutics, Inc.
Assertio Therapeutics is committed to providing responsible solutions to advance patient care in the Company’s core areas of neurology, orphan and specialty medicines. Assertio currently markets three FDA-approved products and continues to identify, license and develop new products that offer enhanced options for patients that may be underserved by existing therapies. To learn more about Assertio, visit www.assertiotx.com.

INVESTOR AND MEDIA CONTACT:
John B. Thomas
SVP, Investor Relations and Corporate Communications
jthomas@assertiotx.com

Assertio Logo.jpg

Source: Assertio Therapeutics, Inc.